In this document, “[***]” indicates that certain confidential information has been redacted from this document because it is both (i) not material to investors and (ii) likely to cause competitive harm to the Company if publicly disclosed. BAW SENSOR...Baw Sensor Supply Agreement • January 24th, 2023 • Zomedica Corp. • Pharmaceutical preparations • New York
This BAW Sensor Supply Agreement (this “Agreement”), dated as of January 17, 2023 (the “Effective Date”) is entered into by and among Qorvo Biotechnologies, LLC having its principal place of business at 14505 21st Ave. N., Suite 212, Plymouth, MN 55447 (“Qorvo”), Zomedica Inc., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica”) and, solely for the purposes of Section 12.5, Zomedica Corp., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica Corp.”). Each of Qorvo and Zomedica may hereafter be referred to as a “Party” or collectively as the “Parties.”
FIRST AMENDMENT TO BAW SENSOR SUPPLY AGREEMENTBaw Sensor Supply Agreement • October 10th, 2023 • Zomedica Corp. • Pharmaceutical preparations
THIS FIRST AMENDMENT TO BAW SENSOR SUPPLY AGREEMENT (this “Amendment”) is entered into this 4th day of October, 2023 (the “Amendment Effective Date”) by and among Qorvo Biotechnologies, LLC, having its principal place of business at 14505 21st Ave. N., Suite 212, Plymouth, MN 55447 (“Qorvo”), Qorvo US, Inc., having its principal place of business at 7628 Thorndike Road, Greensboro, NC 27409-9421 (“Parent”), Zomedica Inc., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica”) and Zomedica Corp., having its principal place of business at 100 Phoenix Drive, Suite 190, Ann Arbor, MI 48108 (“Zomedica Corp.”). Each of Qorvo, Parent and Zomedica may hereafter be referred to as a “Party” or collectively as the “Parties.”
